- Research article
- Open Access
- Open Peer Review
Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular pathology diagnosis at post-mortem
- Imed Gaaloul†1, 2, 5Email author,
- Samira Riabi†1,
- Rafik Harrath1,
- Mark Evans2,
- Nidhal H Salem3,
- Souheil Mlayeh4,
- Sally Huber5 and
- Mahjoub Aouni1
© Gaaloul et al.; licensee BioMed Central Ltd. 2012
- Received: 4 January 2012
- Accepted: 7 September 2012
- Published: 11 September 2012
Viral myocarditis is a major cause of sudden unexpected death in children and young adults. Until recently, coxsackievirus B3 (CVB3) has been the most commonly implicated virus in myocarditis. At present, no standard diagnosis is generally accepted due to the insensitivity of traditional diagnostic tests. This has prompted health professionals to seek new diagnostic approaches, which resulted in the emergence of new molecular pathological tests and a more detailed immunohistochemical and histopathological analysis. When supplemented with immunohistochemistry and molecular pathology, conventional histopathology may provide important clues regarding myocarditis underlying etiology.
This study is based on post-mortem samples from sudden unexpected death victims and controls who were investigated prospectively. Immunohistochemical investigations for the detection of the enteroviral capsid protein VP1 and the characterization and quantification of myocardial inflammatory reactions as well as molecular pathological methods for enteroviral genome detection were performed.
Overall, 48 sudden unexpected death victims were enrolled. As for controls, 37 cases of unnatural traffic accident victims were studied. Enterovirus was detected in 6 sudden unexpected death cases (12.5 %). The control samples were completely enterovirus negative. Furthermore, the enteroviral capsid protein VP1 in the myocardium was detected in enterovirus-positive cases revealed by means of reverse transcriptase-polymerase chain reaction (RT-PCR). Unlike control samples, immunohistochemical investigations showed a significant presence of T and B lymphocytes in sudden unexpected death victims.
Our findings demonstrate clearly a higher prevalence of viral myocarditis in cases of sudden unexpected death compared to control subjects, suggesting that coxsackie B enterovirus may contribute to myocarditis pathogenesis significantly.
- Viral Myocarditis
- Sudden Unexpected Death
- Immunohistochemical Investigation
- Routine Histopathological Examination
From a forensic point of view, sudden death is mainly defined as rapid, unexpected and natural death . Most often, sudden unexpected death due to natural causes results from previously unknown cardiovascular diseases though extra cardiac causes should not be ruled out [1, 2]. Viral myocarditis, defined clinically as an inflammation of the heart muscle caused by viral infection, is an insidious disease and a major cause of sudden unexpected death [1–6] accounting for approximately 20% of cases in adults under 40. More than 20 viruses have been associated with myocarditis, causing mild to severe injury in the myocardium with ultimate manifestation of end-stage dilated cardiomyopathy and heart failure. Among them, CVB3, a small nonenveloped single-stranded and positive-sense RNA genome of the Picornaviridae family and Enterovirus genus , has been implicated in 25% to 40% of acute myocarditis and dilated cardiomyopathy cases in infants and young adolescents. Myocardial inflammation could be detected in 1 to 9% of routine post-mortem examinations . The clinical diagnosis of myocarditis is made difficult by its variable and nonspecific presentations [4, 8–10]. Histopathology is the cornerstone of the diagnosis. A uniform histopathological definition for diagnosis was presented in a consensus statement in 1987 [4, 11–13]. According to Dallas criteria, the histopathological diagnosis of myocarditis is based on necrosis or degeneration of the myocytes (or both) and an adjacent inflammatory infiltrate [11, 12]. However, the histopathological diagnosis of the disorder remains difficult [14, 15]. The relations between the clinical presentation and the histopathological evidence of myocarditis are to be determined. Fatal cases provide a unique opportunity to study these questions as both clinical and histopathological data are available. Furthermore, myocarditis may be falsely recorded as the cause of death if no other obvious causes have been found. In this framework, the current study is aimed at investigating into how accurately viral myocarditis is involved in death when conventional histopathology is supplemented with immunohistochemistry and molecular pathology.
Epidemiological data of investigated groups
SUD victims (n = 48)
Control group (n = 37)
Cause of sudden death
Clinically suspected inflammatory heart disease
Unnatural traffic accident casualties
The research protocol related to the current study was referred to the Ethics and Medical Research Committees of Farhat Hached University Hospital (Sousse) and Fattouma Bourguiba University Hospital (Monastir). Both committees gave their approval. As for the samples, they were taken in compliance with the Tunisian law (Act 91-22; March 25th 1991) pertaining to human organ removal and transplantation. An individual who has reached the age of majority and who is mentally competent may consent to donate his or her organs for therapeutic or scientific purposes. Thus, an organ may be removed from a cadaver for the above mentioned purposes if the deceased individual had not made known while alive his or her refusal to donate and if this procedure was not opposed by any of the people of full legal capacity (children, parents, spouse, siblings, legal guardian). Accordingly, all samples were taken with the informed consent of the deceased individuals’ next of kin.
Histopathology: hematoxylin–eosin staining
The post-mortem myocardial samples taken from each sudden unexpected death victim were fixed in formalin (neutral buffered formaldehyde 30% diluted to 1/10) for 24 hours and embedded in paraffin. The sections (5 μm) were cut from the paraffin-embedded tissues with a microtome. All sections were stained with hematoxylin-eosin staining (Invitrogen: Vermont, USA) and the slides were investigated for myocarditis [16–19].
In all cases, immunohistochemical investigations were performed for CD3-T-lymphocytes (DAKO: Vermont, USA) and CD19-B-lymphocytes (DAKO: Vermont, USA) where the average of counted cells in 20 high power fields (hpf; 400x) was noted. The same investigations were conducted for the enteroviral capsid protein VP1 Mab 5-D8/1 (DAKO: Vermont, USA). Tris-buffered NaCl solution with tween 20, the target retrieval solution, serum-free protein block, antibody diluent, mayer's hematoxylin, EnVision+ system-HRP (AEC) and glycergel® mounting medium aqueous were all purchased from DAKO (Vermont, USA). The Immunohistochemical procedures included antigen exposure, blocking, incubation with primary antibody, incubation with the secondary antibody in the En-Vision detection system, and appropriate wash between steps using Tris-buffered saline with tween 20. All incubations were performed at room temperature [20–23]. Briefly, paraffin-embedded tissue sections (5 μm) were dewaxed with xylene and rehydrated with graded ethanol. Antigen exposure was achieved by heat in a water bath (95-99°C) mediated by target retrieval. The endogenous peroxidase activity was blocked with a peroxidase-blocking reagent for 15 minutes. The tissue sections were blocked with the protein block for 10 minutes and then incubated with primary antibody (appropriately diluted to 1:100-1:500 in antibody diluent) for 30 minutes and washed. The secondary antibody in the En-Vision detection system is the goat anti-mouse Ig conjugated with dextran polymer, on which many peroxidase molecules were labeled. The sections were incubated with this reagent for 30 minutes, washed, and then reacted with substrate chromogen for 5-10 minutes. The slides were immersed in aqueous hematoxylin for counterstaining. The color reaction was stopped by a wash in distilled water. Finally, the mounted sections were examined and confirmed under a Nikon Eclipse 50i microscope.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was extracted from frozen myocardial tissues using the TRIzol®Plus RNA Purification Kit (Invitrogen: Vermont, USA) according to the suppliers’ protocol. DNase treatment during RNA purification was conducted using PureLink™ DNase (Invitrogen: Vermont, USA) in order to obtain DNA-free total RNA. For the detection of enterovirus RNA, One-step RT-PCR was performed with primers directed to the conserved sequences in the 5'-noncoding region of the enterovirus genome. To confirm that the extracted RNA contained enterovirus RNA, a 155 bp gene fragment was amplified with a one-step RT-PCR (Invitrogen SuperScript™ One-Step RT-PCR with Platinum® Taq: Vermont, USA) using 5 μl of extracted viral RNA and two 5'-noncoding region specific primers 006 and 007 . The RT-PCR was performed with 25 μl 2X reaction mix (a buffer containing 0.4 mM of each dNTP, 2.4 mM MgSO4), 0.2 μM each of sense and anti-sense primers, 1 μl enzyme mix (RT/Platinum® Taq; invitrogen: Vermont, USA), and RNase free water up to 50 μl. The reaction was carried out with an initial reverse transcription step at 42°C for 30 minutes followed by PCR activation at 94°C for 5 minutes, 30 amplification cycles (94°C, 30 seconds; 42°C, 1 minute; 72°C, 2 minutes), and a final 10-minute extension at 72°C in an Eppendorf Mastercycler Thermal Cycler. The PCR-products were run on a 2% agarose gel stained with ethidium bromide and visualized under UV-light.
Sequencing and analysis of PCR enterovirus amplification products
The PCR amplicons were purified using the ExoSAP-IT – PCR Clean-Up Reagent (USB® Products from Affymetrix, Inc: Vermont, USA) which represents a one-step enzymatic cleanup of PCR products. Then, they were sequenced in forward and reverse directions with the respective PCR primers. The chromatogram sequencing files were inspected with FinchTV (version 1.4.0). The obtained enterovirus sequences were compared to the corresponding ones available in GenBank using the Basic Local Alignment Search Tool in order to identify the enterovirus type [25, 26].
Histopathological investigation for the detection of inflammatory markers and necrosis factors in the myocardium of sudden unexpected death victims
Immunohistochemical detection of enteroviral capsid protein VP1, CD3-T-lymphocytes and CD19-B-lymphocytes in the myocardium of sudden unexpected death victims
Immunohistochemical and molecular-pathological investigations of the myocardium of sudden unexpected death victims
Enteroviral capsid protein VP1
Coxsackie B enterovirus by RT-PCR
Molecular identification of the enterovirus RNA by RT-PCR and sequencing of PCR enterovirus amplification products
In a cohort of Tunisian sudden unexpected death victims with inflammatory cardiovascular diseases suspected clinically, the enterovirus from both frozen and formalin-fixed paraffin-embedded post-mortem myocardial samples was identified in 12.5% of cases using histopathology supplemented with immunohistochemistry and molecular-pathology. These findings could have a marked impact on the quality of future investigations in such cases. More importantly, the present results and the investigation methods suggested herein would enable pathologists to better understand and elucidate the cause of death. In this study, the positive results were confirmed using a variety of techniques. Frequency and identification of infectious agents in myocarditis cases have varied widely from 10% to 100% [10, 27, 28]. These significant differences stem from several factors including the studied sample (serum, cardiac puncture, frozen heart tissue, formalin-fixed paraffin-embedded myocardial samples), the methods used to detect the infectious agent, result confirmation, correlation with clinical and histopathological findings, and the time of illness when the sample was collected.
Enterovirus represents the most common agent of myocarditis. Viral proteins are synthesized as polyprotein, subsequently cleaved to produce the four capsid proteins VP1 to VP4. RT-PCR as well as other techniques revealed an association between enterovirus infection, in particular the cardiotropic coxsackie B enterovirus, serotypes B1–B5, and myocarditis . As an enterovirus group-specific monoclonal antibody (Mab) is now available, the demonstration of enteroviral antigens in myocardium is possible . In the current study, this Mab was used to detect enteroviral antigens in post-mortem myocardial formalin-fixed, paraffin-embedded sections. To demonstrate the expression of CD3-T-lymphocytes and CD19-B-lymphocytes simultaneously as inflammatory markers, immunostaining was performed. In sudden unexpected death victims, the most remarkable finding was the significant presence of those infiltrates consisting of T and B lymphocytes as compared to the control group samples.
With regard to the time-dependent course of viral myocarditis, as studied in the mouse model, early virus-induced myocardial damage already takes place before the histopathological signs of myocarditis defined by the Dallas criteria can be observed [10, 16]. Myocarditis misdiagnosis in cases of sudden unexpected death can be overcome with a comprehensive combination of molecular pathological assays and immunohistochemical techniques. This has been confirmed by our findings. All the three samples in six of the 48 tested sudden unexpected death victims were stained positive for the enteroviral capsid protein VP1 and were associated with a significant presence of T and B lymphocytes. More intriguing, they all tested positive for enterovirus RNA by RT-PCR. However, a higher prevalence of viral myocarditis can be revealed by the application of a comprehensive combination of molecular pathological analysis for the detection of enterovirus RNA from frozen heart tissues, and immunohistochemical techniques for the detection of the enteroviral capsid protein VP1 and both CD3-T-lymphocytes and CD19-B-lymphocytes from formalin-fixed, paraffin-embedded heart tissue. This is of great importance when a routine histopathological examination alone does not yield reliable findings in heart muscle tissue.
In conclusion, the present study based on sudden unexpected death cases on the coast of Tunisia demonstrates clearly a higher prevalence of viral myocarditis suggesting that coxsackie B enterovirus may contribute to myocarditis pathogenesis significantly. The combined investigations using histopathology, molecularpathological techniques and immunohistochemical methods were able to reveal the causative agents of death. Prospective murin experimental myocarditis would be desirable and could have a marked impact on the quality of future investigations to better understand and elucidate the physio and immuno-pathogenesis of such infectious heart diseases.
This study was supported by the National Institute of Health grant (HL108371).
The authors would like to thank Mr. Adel Rdissi for proof-reading the article.
- Grandmaison GL: Is there progress in the autopsy diagnosis of sudden unexpected death in adults?. Forensic Sci Int. 2006, 156: 138-144. 10.1016/j.forsciint.2004.12.024.View ArticlePubMedGoogle Scholar
- Steinberger J, Lucas RV, Edwards JE, Titus JL: Causes of sudden unexpected cardiac death in the first two decades of life. Am J Cardiol. 1996, 77: 992-995. 10.1016/S0002-9149(96)00035-5.View ArticlePubMedGoogle Scholar
- D’Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G: The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001, 85: 499-504. 10.1136/heart.85.5.499.View ArticlePubMedPubMed CentralGoogle Scholar
- Kytö V, Saukko P, Lignitz E, Schwesinger G, Henn V, Saraste A, Voipio-Pulkki L-M: Diagnosis and presentation of fatal myocarditis. Hum Pathol. 2005, 36: 1003-1007. 10.1016/j.humpath.2005.07.009.View ArticlePubMedGoogle Scholar
- Zack F, Klingel K, Kandolf R, Wegener R: Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int. 2005, 155: 13-17. 10.1016/j.forsciint.2004.10.023.View ArticlePubMedGoogle Scholar
- Fengqin L, Yulin W, Xiaoxin Z, Youpeng J, Yan C, Qing-qing W, Hong C, Jia S, Lei H: The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3. J Ethnopharmacol. 2010, 127: 221-228. 10.1016/j.jep.2009.11.017.View ArticlePubMedGoogle Scholar
- Esfandiarei M, Suarez A, Amaral A, Si X, Rahmani M, Dedhar S, McManus BM: Novel Role for Integrin-Linked Kinase in Modulation of Coxsackievirus B3 Replication and Virus-Induced Cardiomyocyte Injury. Circ Res. 2006, 99: 354-361. 10.1161/01.RES.0000237022.72726.01.View ArticlePubMedGoogle Scholar
- Gardiner AJ, Short D: Four faces of acute myopericarditis. Br Heart J. 1973, 35: 433-442. 10.1136/hrt.35.4.433.View ArticlePubMedPubMed CentralGoogle Scholar
- Mason JW: Distinct forms of myocarditis. Circulation. 1991, 83: 1110-1111. 10.1161/01.CIR.83.3.1110.View ArticlePubMedGoogle Scholar
- Feldman AM, McNamara D: Myocarditis. N Engl J Med. 2000, 343: 1388-1398. 10.1056/NEJM200011093431908.View ArticlePubMedGoogle Scholar
- Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ: Myocarditis: A histopathological definition and classifications. Am J Cardiovasc Pathol. 1987, 1: 3-14.PubMedGoogle Scholar
- Aretz HT: Myocarditis: the Dallas criteria. Hum Pathol. 1987, 18: 619-624. 10.1016/S0046-8177(87)80363-5.View ArticlePubMedGoogle Scholar
- Baughman KL: Diagnosis of Myocarditis Death of Dallas Criteria. Circulation. 2006, 113: 593-595. 10.1161/CIRCULATIONAHA.105.589663.View ArticlePubMedGoogle Scholar
- Peters NS, Poole-Wilson PA: Myocarditis-continuing clinical and pathologic confusion. Am Heart J. 1991, 121: 942-947. 10.1016/0002-8703(91)90221-3.View ArticlePubMedGoogle Scholar
- Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: and the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995, 333: 269-275. 10.1056/NEJM199508033330501.View ArticlePubMedGoogle Scholar
- Cioc AM, Nuovo GJ: Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death. Mod Pathol. 2001, 15: 914-922.View ArticleGoogle Scholar
- Dettmeyer R, Kandolf R, Schmidt P, Schlamann M, Madea B: Lympho monocytic enteroviral myocarditis traditional, immunohistological and molecularpathological methods for diagnosis in a case of suspected sudden infant death syndrome (SIDS). Forensic Sci Int. 2001, 119: 141-144. 10.1016/S0379-0738(00)00413-8.View ArticlePubMedGoogle Scholar
- Guarner J, Bhatnagar J, Shieh WJ, Nolte KB, Klein D, Gookin MS, Penaranda S, Oberste MS, Jones T, Smith C, Pallansch MA, Zaki SR: Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis. Hum Pathol. 2007, 38: 1412-1419. 10.1016/j.humpath.2007.02.012.View ArticlePubMedGoogle Scholar
- Chimenti C, Frustaci A: Histopathology of myocarditis. Diagn Histopathol. 2008, 14: 40-407.View ArticleGoogle Scholar
- Shi SR, Key ME, Kalra KL: Antigen retrieval in formalinfixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991, 39: 741-748. 10.1177/39.6.1709656.View ArticlePubMedGoogle Scholar
- Shi SR, Cote RJ, Taylor CR: Antigen retrieval immunohistochemistry: past, present and future. J Histochem Cytochem. 1997, 45: 327-343. 10.1177/002215549704500301.View ArticlePubMedGoogle Scholar
- Sabattini E, Bisgard K, Ascani SS: Poggi, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri S A. The EnVision system: a new immunohistochemical method for diagnostics and research: critical comparison with the APAAP, ChemMate, CSA, LABC and SABC techniques. J Clin Pathol. 1998, 51: 506-511. 10.1136/jcp.51.7.506.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang H, Li Y, Peng T, Aasa M, Zhang L, Yang Y, Archard LC: Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique. J Histochem Cytochem. 2000, 48 (5): 579-584. 10.1177/002215540004800501.View ArticlePubMedGoogle Scholar
- Zoll GJ, Melchers WJG, Kopecka H, Jambroes G, Van Der Poel HJA, Galama JMD: General Primer-Mediated Polymerase Chain Reaction for Detection of Enteroviruses: Application for Diagnostic Routine and Persistent Infections. J Clin Microbiol. 1992, 30: 160-165.PubMedPubMed CentralGoogle Scholar
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol. 1990, 215: 403-410.View ArticlePubMedGoogle Scholar
- Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA: Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol. 2000, 38: 1170-1174.PubMedPubMed CentralGoogle Scholar
- Cambridge M, MacArthur C, Waterson A, Goodwin J, Oakley C: Antibodies to coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1997, 41: 692-696.View ArticleGoogle Scholar
- Bowles NE, Ni J, Kearney D, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA: Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003, 42: 466-472. 10.1016/S0735-1097(03)00648-X.View ArticlePubMedGoogle Scholar
- Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC: Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation. 1990, 82: 8-16. 10.1161/01.CIR.82.1.8.View ArticlePubMedGoogle Scholar
- Li Y, Bourlet T, Andreoletti L, Mosnier JF, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H: Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation. 2000, 101: 231-234. 10.1161/01.CIR.101.3.231.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/212/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.